scorecardresearch
Wockhardt

Wockhardt

 

More Stories on Wockhardt
The company will make 100 million doses of Sputnik V/Sputnik Light by June 2022

Wockhardt plans largescale contract manufacturing of Covid-19 vaccines

Aug 24, 2021

The company has already started manufacturing trial batches (for regulatory purposes) following technology transfer in April from the Russian Direct Investment Fund (RDIF)

Sputnik V to be produced by Wockhardt

Mumbai-based Wockhardt to manufacture Russian vaccines Sputnik V, Sputnik Light 

Aug 13, 2021

Wockhardt will manufacture and supply 620 million doses of Sputnik V and Sputnik Light by June 2023

Stocks to watch today on December 2

Stocks in news: ICICI Bank, YES Bank, Dr Reddy, Wockhardt, Ajanta Pharma, Coal India, Vodafone

Dec 02, 2020

Stocks to watch today on December 2: ICICI Bank, YES Bank, Dr Reddy, Wockhardt, Ajanta Pharma, Coal India, Vodafone among others are the top stocks to watch out for in Wednesday's trading session

The vaccine is co-invented by the University of Oxford and its spin-out company, Vaccitech and licensed by AstraZeneca

Wockhardt share price jumps 10% on Covid-19 vaccine deal with UK

Aug 04, 2020

Market cap of Wockhardt rose to Rs 3,695.50 crore as of today's session. The stock price of Wockhardt has gained 21% in one month and 42% since the beginning of the year

Wockhardt announced it inked an agreement with the UK government to fill-finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

Wockhardt stock closes 10% higher on COVID vaccine deal with UK

Aug 03, 2020

Wockhardt  stock has gained 18.1% in the last 5 days

An important large clinical trial among 2,104 patients in the UK initiated by the University of Oxford has proved the drug can reduce deaths by one-third in ventilated coronavirus patients

Lifesaving coronavirus drug Dexamethasone costs less than 30 paise; 20 cos sell in India

Jun 17, 2020

India exports 5.35 lakh tonnes of Dexamethasone worth $15.34 million. US is the bigger buyer worth $5.17 million, Nigeria $ 1.88 million, Canada $1.02 million, Russian Federation $0.92 million and Uganda $0.91 million

Sun Pharma share trades higher than 20 day, 50 day, 100 day and 200 day moving averages but lower than 5 day moving averages.

Sun Pharma share price gains 52% from March lows; time to buy, sell or hold the stock?

Jun 12, 2020

Sun Pharma share price gained up to 1.56% to Rs 481 against previous close of Rs 473.60 on BSE. The pharma stock has gained after 2 days of consecutive fall

According to a statement issued by the office of the Attorney General, the topical drugs at the centre of the complaint include creams, gels, lotions, ointments, shampoos, and solutions used to treat a variety of skin conditions, pain, and allergies

Indian pharma companies Aurobindo, Glenmark, Lupin, Sun, Wockhardt dragged to court in US

Jun 11, 2020

The multistate law suit filed by Maryland Attorney General Brian E. Frosh on June 10 alleges a broad conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States

Representative Image

Dr Reddy's to keep cutting China dependence; logistics hurdles hurt India sales

May 20, 2020

Sharing the numbers and providing details of the business, The NYSE-listed firm's co-chairman and MD, G V Prasad, CEO Erez Israeli and President and CFO Saumen Chakraborty set up a zoom meeting

Here's a look at the updates of the market action on BSE and NSE today

Share Market Update: Sensex ends 81 points lower, Nifty at 9,239; ICICI Bank, Dr Reddy, BPCL, HDFC top losers

May 11, 2020

Sensex, Nifty Live News Today: Market experts said markets sentiments tunred cautious, with Bank Nifty turning negative following reports that FM's meet with Public Sector Banks was rescheuled to later this week.

Representative Image

BT Buzz: How to keep cash-burning hospitals alive in coronavirus times

Apr 22, 2020

Although big players are expecting 50 per cent cut in earnings, they are still in a better position than smaller ones to raise bank loans. However, the uncertainty around how long the corona crisis will last will add to their problems